Kiniksa Pharmaceuticals International, plc (KNSA) › Weighted Average Diluted SharesKiniksa Pharmaceuticals International, plc (KNSA) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-12-31: 54.05M2020-12-31: 61.84M2021-12-31: 68.58M2022-12-31: 70.42M2023-12-31: 71.92M2024-12-31: 71.42M2025-12-31: 78.98M78.98M2019-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3178.98M+10.6%2026-02-24From 2025-01-012024-12-3171.42M-0.7%2026-02-24From 2024-01-012023-12-3171.92M+2.1%2026-02-24From 2023-01-012022-12-3170.42M+2.7%2025-02-25From 2022-01-012021-12-3168.58M+10.9%2024-02-28From 2021-01-012020-12-3161.84M+14.4%2023-03-02From 2020-01-012019-12-3154.05M—2022-02-24From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)